secwatch.observer — SEC 8-K summary
======================================

Issuer:     Embecta Corp. (EMBC)
CIK:        0001872789
Form:       8-K
Filed at:   2022-02-11T23:59:59+00:00
Accession:  0001193125-22-035814
Event type: other_material
Sentiment:  neutral
Materiality: 0.75
Item codes: 1.01, 2.03, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Embecta sets April 1 spin-off from BD; issues $500M senior secured notes due 2030
--------------------------------------------------------------------------------

- BD to distribute 1 Embecta share for every 5 BD shares held on March 22, 2022; distribution expected April 1, 2022.
- Embecta common stock to list on Nasdaq under symbol 'EMBC' after separation.
- Embecta issued $500M of 5.000% senior secured notes due 2030, secured by assets post-spin.
- Separation intended to be tax-free for BD shareholders (except cash in lieu of fractional shares).
- Embecta will be independent pure-play diabetes care company; produces ~7.6B units of injection devices annually.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1872789/000119312522035814/0001193125-22-035814-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1872789/000119312522035814/d669833d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-22-035814

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer